Mariam O. Fofana, MD, PhD

• A David Paltiel
• Albert Ko
• Federico Costa
• Mitermayer Reis
• Ted Cohen

Global Health; Infectious Diseases; Modeling

• Willingness to Get the COVID-19 Vaccine among Residents of Slum Settlements.Aguilar Ticona JP, Nery N, Victoriano R, Fofana MO, Ribeiro GS, Giorgi E, Reis MG, Ko AI, Costa F. Willingness to Get the COVID-19 Vaccine among Residents of Slum Settlements. Vaccines 2021, 9 PMID: 34579188, PMCID: PMC8472908, DOI: 10.3390/vaccines9090951.
• The Deepest Cuts.Fofana MO. The Deepest Cuts. Annals Of Emergency Medicine 2021, 78: 453-454. PMID: 34420558, DOI: 10.1016/j.annemergmed.2021.03.011.
• Time and time again: the reincarnations of coerced sterilisation.Fofana MO. Time and time again: the reincarnations of coerced sterilisation. Journal Of Medical Ethics 2021 PMID: 34127527, DOI: 10.1136/medethics-2020-106924.
• Decolonising global health in the time of COVID-19.Fofana MO. Decolonising global health in the time of COVID-19. Global Public Health 2021, 16: 1155-1166. PMID: 33370211, DOI: 10.1080/17441692.2020.1864754.
• A Multistrain Mathematical Model To Investigate the Role of Pyrazinamide in the Emergence of Extensively Drug-Resistant Tuberculosis.Fofana MO, Shrestha S, Knight GM, Cohen T, White RG, Cobelens F, Dowdy DW. A Multistrain Mathematical Model To Investigate the Role of Pyrazinamide in the Emergence of Extensively Drug-Resistant Tuberculosis. Antimicrobial Agents And Chemotherapy 2017, 61 PMID: 27956422, PMCID: PMC5328532, DOI: 10.1128/AAC.00498-16.
• Development of global health education at Johns Hopkins University School of Medicine: a student-driven initiative.Moran D, Edwardson J, Cuneo CN, Tackett S, Aluri J, Kironji A, Cox J, Carroll B, Lie E, Fofana M, Bollinger RC, Ziegelstein RC, Chen CC. Development of global health education at Johns Hopkins University School of Medicine: a student-driven initiative. Medical Education Online 2015, 20: 28632. PMID: 26220909, PMCID: PMC4518163, DOI: 10.3402/meo.v20.28632.
• Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis.Kendall EA, Fofana MO, Dowdy DW. Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis. The Lancet. Respiratory Medicine 2015, 3: 963-72. PMID: 26597127, PMCID: PMC4684734, DOI: 10.1016/S2213-2600(15)00458-0.
• The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis.Knight GM, Colijn C, Shrestha S, Fofana M, Cobelens F, White RG, Dowdy DW, Cohen T. The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis. Clinical Infectious Diseases : An Official Publication Of The Infectious Diseases Society Of America 2015, 61Suppl 3: S147-54. PMID: 26409276, PMCID: PMC4583567, DOI: 10.1093/cid/civ579.
• Population-level impact of shorter-course regimens for tuberculosis: a model-based analysis.Fofana MO, Knight GM, Gomez GB, White RG, Dowdy DW. Population-level impact of shorter-course regimens for tuberculosis: a model-based analysis. PloS One 2014, 9: e96389. PMID: 24816692, PMCID: PMC4015982, DOI: 10.1371/journal.pone.0096389.
• Drivers and trajectories of resistance to new first-line drug regimens for tuberculosis.Shrestha S, Knight GM, Fofana M, Cohen T, White RG, Cobelens F, Dowdy DW. Drivers and trajectories of resistance to new first-line drug regimens for tuberculosis. Open Forum Infectious Diseases 2014, 1: ofu073. PMID: 25734143, PMCID: PMC4281792, DOI: 10.1093/ofid/ofu073.
• The spectre of race in American medicine.Fofana MO. The spectre of race in American medicine. Medical Humanities 2013, 39: 137-41. PMID: 23988563, PMCID: PMC4131435, DOI: 10.1136/medhum-2013-010374.
• Cost-effectiveness of novel first-line treatment regimens for tuberculosis.Owens JP, Fofana MO, Dowdy DW. Cost-effectiveness of novel first-line treatment regimens for tuberculosis. The International Journal Of Tuberculosis And Lung Disease : The Official Journal Of The International Union Against Tuberculosis And Lung Disease 2013, 17: 590-6. PMID: 23575322, PMCID: PMC3844288, DOI: 10.5588/ijtld.12.0776.
• The clinical impact and cost-effectiveness of routine, voluntary HIV screening in South Africa.Walensky RP, Wood R, Fofana MO, Martinson NA, Losina E, April MD, Bassett IV, Morris BL, Freedberg KA, Paltiel AD. The clinical impact and cost-effectiveness of routine, voluntary HIV screening in South Africa. Journal Of Acquired Immune Deficiency Syndromes (1999) 2011, 56: 26-35. PMID: 21068674, PMCID: PMC3005842, DOI: 10.1097/QAI.0b013e3181fb8f24.
• When to start antiretroviral therapy in resource-limited settings.Walensky RP, Wolf LL, Wood R, Fofana MO, Freedberg KA, Martinson NA, Paltiel AD, Anglaret X, Weinstein MC, Losina E. When to start antiretroviral therapy in resource-limited settings. Annals Of Internal Medicine 2009, 151: 157-66. PMID: 19620143, PMCID: PMC3092478, DOI: 10.7326/0003-4819-151-3-200908040-00138.
• Scaling up antiretroviral therapy in South Africa: the impact of speed on survival.Walensky RP, Wood R, Weinstein MC, Martinson NA, Losina E, Fofana MO, Goldie SJ, Divi N, Yazdanpanah Y, Wang B, Paltiel AD, Freedberg KA. Scaling up antiretroviral therapy in South Africa: the impact of speed on survival. The Journal Of Infectious Diseases 2008, 197: 1324-32. PMID: 18422445, PMCID: PMC2423492, DOI: 10.1086/587184.